Xeris Biopharma Holdings, Inc. (XERS) Form 10-Q Quarterly Reports
Xeris Biopharma Holdings, Inc. (XERS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XERS
CIK: 1867096
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerJoseph Ponstein
Audit LocationGrand Rapids, Michigan, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-13 | 8-K | 0001867096-26-000091 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001867096-26-000086 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001867096-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001867096-26-000084 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009959 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-28 | FORM 4 | 0001867096-26-000078 | View SEC Doc Filr Page |
| 144 | 2026-09-28 | — | 144 Filing | 0001950047-26-009839 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001867096-26-000077 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | FORM 4 | 0002031695-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | FORM 4 | 0001652410-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | FORM 4 | 0001875714-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-01 | FORM 4 | 0001867096-26-000073 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-01 | FORM 4 | 0001867096-26-000069 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-12 | FORM 4 | 0001875714-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008033 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001867096-26-000065 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001867096-26-000063 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | FORM 4 | 0001867096-26-000059 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | FORM 4 | 0001652410-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001430 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-15 | 8-K | 0001867096-26-000055 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-06 | FORM 4 | 0001875714-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-07-07 | — | 144 Filing | 0001950047-26-006941 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001950047-26-006884 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001741850-26-000002 | View SEC Doc Filr Page |